APA (7th ed.) Citation

Stamatakos, S., Beretta, G. L., Vergani, E., Dugo, M., Corno, C., Corna, E., . . . Griffioen, A. W. (2021). Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations. Cancers, 13(9), 2284. https://doi.org/10.3390/cancers13092284

Chicago Style (17th ed.) Citation

Stamatakos, Serena, et al. "Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations." Cancers 13, no. 9 (2021): 2284. https://doi.org/10.3390/cancers13092284.

MLA (9th ed.) Citation

Stamatakos, Serena, et al. "Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations." Cancers, vol. 13, no. 9, 2021, p. 2284, https://doi.org/10.3390/cancers13092284.